Investing in Infection Prevention and Control to Contain Antibiotic Resistance: Progress is Achievable

Investing in Infection Prevention and Control to Contain Antibiotic Resistance: Progress is Achievable

Mon, 05/14/2018 - 02:01
0 comments

In many low- and middle-income countries, infection prevention and control (IPC) is an often overlooked, but critical, capacity for safe clinical care, including the reduction and containment of antimicrobial resistant (AR) pathogens.  Around the world, there remain fundamental gaps in IPC capacity and implementation, with many efforts limited to temporary stop-gap measures, e.g., during emergencies. 

By Benjamin J. Park*, Denise Cardo*, Michael Bell*

* Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infections, Centers for Diseases Control and Prevention (CDC), Atlanta, GA USA

Read more on www.amrcontrol.info